Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Gastric Proteins MUC5AC and TFF1 as Potential Diagnostic Markers of Colonic Sessile Serrated Adenomas/Polyps.

Khaidakov M, Lai KK, Roudachevski D, Sargsyan J, Goyne HE, Pai RK, Lamps LW, Hagedorn CH.

Am J Clin Pathol. 2016 Nov 1;146(5):530-537. doi: 10.1093/ajcp/aqw142.

2.
3.
4.

Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.

Liu JC, Hao WR, Hsu YP, Sung LC, Kao PF, Lin CF, Wu AT, Yuan KS, Wu SY.

Oncotarget. 2016 Oct 4;7(40):65270-65283. doi: 10.18632/oncotarget.11263.

5.

Inflammatory response in serrated precursor lesions of the colon classified according to WHO entities, clinical parameters and phenotype-genotype correlation.

Rau TT, Atreya R, Aust D, Baretton G, Eck M, Erlenbach-Wünsch K, Hartmann A, Lugli A, Stöhr R, Vieth M, Wirsing AM, Zlobec I, Katzenberger T.

J Pathol Clin Res. 2016 Feb 25;2(2):113-24. doi: 10.1002/cjp2.41. eCollection 2016 Apr.

6.

Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.

Murcia O, Juárez M, Hernández-Illán E, Egoavil C, Giner-Calabuig M, Rodríguez-Soler M, Jover R.

World J Gastroenterol. 2016 Apr 7;22(13):3516-30. doi: 10.3748/wjg.v22.i13.3516. Review.

7.

Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.

Yi C, Huang Y, Yu X, Li X, Zheng S, Ding K, Xu J.

Oncotarget. 2016 Mar 29;7(13):17265-74. doi: 10.18632/oncotarget.7504.

8.

Expression of PI3Kp110α and PI3Kp110β in the colorectal conventional adenoma, serrated lesions and adenoma with canceration and their significance.

Wu S, Li T, Mu Q, Li Y, Gao X, He S, Sun C.

Int J Clin Exp Pathol. 2015 Dec 1;8(12):16026-35. eCollection 2015.

9.

Serrated polyps of the colon and rectum: Endoscopic features including image enhanced endoscopy.

Saito S, Tajiri H, Ikegami M.

World J Gastrointest Endosc. 2015 Jul 25;7(9):860-71. doi: 10.4253/wjge.v7.i9.860. Review.

10.

Clinicopathologic Significance of BRAF Mutation and Extracellular Signal Regulated Kinase 1/2 Expression in Patients With a Colorectal Adenocarcinoma.

Kim HO, Kim BG, Cha SJ, Park YG, Lee TJ.

Ann Coloproctol. 2015 Feb;31(1):9-15. doi: 10.3393/ac.2015.31.1.9. Epub 2015 Feb 28.

11.

The molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screening.

Grady WM, Markowitz SD.

Dig Dis Sci. 2015 Mar;60(3):762-72. doi: 10.1007/s10620-014-3444-4. Epub 2014 Dec 10. Review.

12.

B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P.

Inoue A, Okamoto K, Fujino Y, Nakagawa T, Muguruma N, Sannomiya K, Mitsui Y, Takaoka T, Kitamura S, Miyamoto H, Okahisa T, Fujimori T, Imoto I, Takayama T.

Br J Cancer. 2015 Jan 20;112(2):403-12. doi: 10.1038/bjc.2014.545. Epub 2014 Oct 14.

13.

Screening, management and surveillance for the sessile serrated adenomas/polyps.

Fu X, Qiu Y, Zhang Y.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1275-85. eCollection 2014. Review.

14.

The CIMP Phenotype in BRAF Mutant Serrated Polyps from a Prospective Colonoscopy Patient Cohort.

Fernando WC, Miranda MS, Worthley DL, Togashi K, Watters DJ, Leggett BA, Spring KJ.

Gastroenterol Res Pract. 2014;2014:374926. doi: 10.1155/2014/374926. Epub 2014 Apr 10.

15.

Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer.

Luo Y, Wong CJ, Kaz AM, Dzieciatkowski S, Carter KT, Morris SM, Wang J, Willis JE, Makar KW, Ulrich CM, Lutterbaugh JD, Shrubsole MJ, Zheng W, Markowitz SD, Grady WM.

Gastroenterology. 2014 Aug;147(2):418-29.e8. doi: 10.1053/j.gastro.2014.04.039. Epub 2014 Apr 30.

16.

Serrated pathway in colorectal carcinogenesis.

Yamane L, Scapulatempo-Neto C, Reis RM, Guimarães DP.

World J Gastroenterol. 2014 Mar 14;20(10):2634-40. doi: 10.3748/wjg.v20.i10.2634. Review.

17.

RNA sequencing of sessile serrated colon polyps identifies differentially expressed genes and immunohistochemical markers.

Delker DA, McGettigan BM, Kanth P, Pop S, Neklason DW, Bronner MP, Burt RW, Hagedorn CH.

PLoS One. 2014 Feb 12;9(2):e88367. doi: 10.1371/journal.pone.0088367. eCollection 2014.

18.

CpG island methylator phenotype and its association with malignancy in sporadic duodenal adenomas.

Sun L, Guzzetta AA, Fu T, Chen J, Jeschke J, Kwak R, Vatapalli R, Baylin SB, Iacobuzio-Donahue CA, Wolfgang CL, Ahuja N.

Epigenetics. 2014 May;9(5):738-46. doi: 10.4161/epi.28082. Epub 2014 Feb 11.

19.

Toward a Molecular Classification of Colorectal Cancer: The Role of MGMT.

Minoo P.

Front Oncol. 2013 Oct 18;3:266. doi: 10.3389/fonc.2013.00266. Review.

20.

Shifted termination assay (STA) fragment analysis to detect BRAF V600 mutations in papillary thyroid carcinomas.

Kang SY, Ahn S, Lee SM, Jeong JY, Sung JY, Oh YL, Kim KM.

Diagn Pathol. 2013 Jul 24;8:121. doi: 10.1186/1746-1596-8-121.

Supplemental Content

Support Center